Colospan Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $4.5M

Colospan General Information

Description

Developer of an intraluminal bypass device designed to reduce the rate of diverting stomas and their related complications. The company's devices contain an alternative to divert stoma by providing a temporary intraluminal bypass which helps in reducing the contact of fecal materials with the anastomotic site, reducing the life-threatening symptoms related to clinical anastomotic leaks, enabling doctors to maintain patients' well-being safely and effectively and minimizing post-operative complications for a comfortable recovery.

Contact Information

Website
www.colospan.com
Formerly Known As
Cologuard
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 21 Atir Yeda Street
  • Kfar Saba 4464316
  • Israel
+972
Primary Industry
Surgical Devices
Vertical(s)
Digital Health, HealthTech
Corporate Office
  • 21 Atir Yeda Street
  • Kfar Saba 4464316
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Colospan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 22-Jun-2026 $4.5M Completed Clinical Trials - General
7. Later Stage VC 27-Jan-2023 Completed Clinical Trials - General
6. Later Stage VC 20-Dec-2021 Completed Clinical Trials - General
5. Grant 06-Oct-2021 Completed Clinical Trials - General
4. Later Stage VC 24-Sep-2017 Completed Clinical Trials - General
3. Grant 12-Dec-2016 Completed Clinical Trials - General
2. Later Stage VC 03-Feb-2016 $2.5M $2.5M Completed Clinical Trials - General
1. Early Stage VC Completed Startup
To view Colospan’s complete valuation and funding history, request access »

Colospan Patents

  • 29

    Total Documents Applications and Grants

  • Total Patents Families

  • 20

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Colospan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026527455-A Fitting of patient-specific intraluminal devices Pending 26-Jul-2023
EP-4750382-A1 Patient-specific intraluminal device fitting Pending 26-Jul-2023
WO-2025022376-A1 Patient-specific intraluminal device fitting Inactive 26-Jul-2023
EP-3206634-A2 Apparatus for delivering a device to a hollow organ Active 14-Oct-2014
EP-3206634-A4 Apparatus for delivering a device to a hollow organ Active 14-Oct-2014 A61B17/00234
To view Colospan’s complete patent history, request access »

Colospan Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Colospan FAQs

  • When was Colospan founded?

    Colospan was founded in 2010.

  • Where is Colospan headquartered?

    Colospan is headquartered in Kfar Saba, Israel.

  • What is the size of Colospan?

    Colospan has 11 total employees.

  • What industry is Colospan in?

    Colospan’s primary industry is Surgical Devices.

  • Is Colospan a private or public company?

    Colospan is a Private company.

  • What is the current valuation of Colospan?

    The current valuation of Colospan is .

  • What is Colospan’s current revenue?

    The current revenue for Colospan is .

  • How much funding has Colospan raised over time?

    Colospan has raised $20.9M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process